Dividends Calendar Earnings Calendar
ALNY

ALNY | Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals Inc
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Cambridge, Massachusetts, United States

Trade prices

  • Volume:
  • Market Cap: 17.91B
  • Prev closed: 165.11
  • Open: 165.46
  • High: 169.93
  • Low: 162.25
  • 52 week low: 84.97
  • 52 week high: 178.41
  • Dividends:No Dividends

Next ER: July 28, 2022  Before Market Opens



Top Stories (ALNY)

    About the Company

    Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    October 27, 2022
    July 28, 2022-2.29 / -1.61224.82M / 255.87M
    April 28, 2022-2 / -1.81213.26M / 240.95M
    February 10, 2022-2.16 / -1.55258.54M / 233.61MBeat!
    October 28, 2021-1.72 / -1.54187.63M / 218.72M
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Jul 28, 2022 143.52 137.00
    145.28
    135.51
    537.78K 1.09%
    Jul 27, 2022 141.97 140.62
    142.67
    137.04
    774.99K 1.41%
    Jul 26, 2022 140.00 141.96
    142.75
    137.02
    667.49K -0.85%
    Jul 25, 2022 141.20 143.00
    143.15
    139.59
    471.09K -1.4%
    Jul 22, 2022 143.21 148.51
    148.51
    143.01
    550.59K -2.71%
    Jul 21, 2022 147.20 146.56
    149.14
    146.42
    425.73K 0.44%
    Jul 20, 2022 146.56 146.63
    149.72
    144.90
    436.60K 0.58%
    Jul 19, 2022 145.72 143.02
    145.86
    141.59
    442.89K 3.61%
    Jul 18, 2022 140.64 145.53
    147.74
    140.00
    556.58K -3.27%
    Jul 15, 2022 145.39 138.16
    146.40
    138.04
    994.22K 4.94%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:June 2002
    • Employees:1,323 (2019)

    News

    News for (ALNY)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  John Maraganore (Dec 2002–)

    Talk about Alnylam Pharmaceuticals Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Jul 28, 2022 (Same day)

    amzn intc fslr aapl hsy ma htz cmcsa amt hog emn pbf 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 42
    HOLD 58
    SELL 0

    Their Official Profiles 

    WikipediaTwitterLinkedInYoutube

    Peers / Similar stocks 

    xlv 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Intelligent Investor
    Buy on Amazon

    Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.

    The best book on investing ever written.
    -- Warren Buffet